-
Mashup Score: 0Dealing with Side Effects: Can Marijuana Be Beneficial? - 4 year(s) ago
Dr. Lorenzo Cohen and Dr. Robert Orlowski, along with myeloma patient Zoe, discuss the use of marijuana for medicinal purposes. While marijuana is not yet legal in every state, the experts share the research that shows improvement in appetite and pain.
Source: Patient PowerCategories: Latest Headlines, Onc News and JournalsTweet
-
Mashup Score: 0Outcomes in Patients With Retroperitoneal Soft-Tissue Sarcoma by Hospital Type - The ASCO Post - 4 year(s) ago
By Matthew Stenger Posted: 4/15/2020 1:38:00 PM Last Updated: 4/17/2020 2:56:41 PM In a study reported in JCO Oncology Practice, Villano et al found that increased hospital surgical volume was associated with overall improved survival in patients undergoing surgery for…
Source: www.ascopost.comCategories: Latest Headlines, Onc News and JournalsTweet-
Outcomes in Patients With Retroperitoneal Soft-Tissue Sarcoma by Hospital Type https://t.co/b9N54Mla95 #oncology #scmsm #cancer
-
-
Mashup Score: 2NYC doctor praises courageous staff working in a 'war zone' - 4 year(s) ago
Dr. Philip Ozuah, CEO of Montefiore Medicine, discusses how Montefiore hospitals have responded to the coronavirus in New York City.
Source: MSNBC.comCategories: Latest Headlines, Onc News and JournalsTweet-
RT @jonathanealpert: #Montefiore in the battle against #COVID-19 #StayStrong Dr. Ozuah praises staff https://t.co/LiGyZO2MES via @msnbc
-
-
Mashup Score: 0The Coronavirus in America: The Year Ahead - 4 year(s) ago
There will be no quick return to our previous lives, according to nearly two dozen experts. But there is hope for managing the scourge now and in the long term.
Source: www.nytimes.comCategories: Latest Headlines, Onc News and JournalsTweet-
The record for bringing any vaccine to market is 4 years. So why is everyone assuming there will be one this year or next? The Coronavirus in America: The Year Ahead https://t.co/L7l0DqVr33 https://t.co/yPJneaPxyD
-
-
Mashup Score: 4FDA Approves Pemigatinib for Advanced Cholangiocarcinoma - 4 year(s) ago
This is the first FDA approval for this patient population.
Source: Cancer NetworkCategories: Latest Headlines, Onc News and JournalsTweet-
The @FDAOncology approved pemigatinib (Pemazyre) for the treatment of patients with previously treated, advanced cholangiocarcinoma, a rare form of cancer in the bile ducts. https://t.co/8vHxSffjEY https://t.co/EJpcJpKOCO
-
Multiple Myeloma | Can #marijuana help patients dealing with side effects related to #multiplemyeloma? Drs. Lorenzo Cohen and Dr. Robert Orlowski from @MDAndersonNews and #myeloma patient Zoe discuss this sometimes controversial topic. https://t.co/ttUQZAl5au #mmsm #chemobrain https://t.co/6NFm3qDfSa